Popular Heart Medications Can Prevent Herceptin-Induced Heart Issues in Some Patients
March 11, 2018
March 11, 2018
ORLANDO, Florida, March 11 -- The American College of Cardiology issued the following news release:
Breast cancer patients who started taking one of two well-known heart medications at the same time they initiated trastuzumab--a targeted cancer therapy that has been linked to heart damage--received no benefit in terms of preventing declines in heart function, according to research presented at the American College of Cardiology's 67th Annual Scientific Session. However, in patients . . .
Breast cancer patients who started taking one of two well-known heart medications at the same time they initiated trastuzumab--a targeted cancer therapy that has been linked to heart damage--received no benefit in terms of preventing declines in heart function, according to research presented at the American College of Cardiology's 67th Annual Scientific Session. However, in patients . . .